PGIM Jennison Health Sciences Fund- Class R (PJHRX) is a Health fund with $2.61 Billion in assets. The fund allocates 50.58% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co at 13.06% of total assets. This is followed by UnitedHealth Group Inc (4.76%) and Amgen Inc (4.85%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co | 13.06% | - | - |
| UnitedHealth Group Inc | 4.76% | - | - |
| Amgen Inc | 4.85% | - | - |
| Bristol-Myers Squibb Co | 4.80% | - | - |
| Vertex Pharmaceuticals Inc | 4.39% | - | - |
| Novo Nordisk A/S | 3.67% | - | - |
| Boston Scientific Corp | 3.44% | - | - |
| Argenx SE | 4.20% | - | - |
| Humana Inc | 3.39% | - | - |
| AstraZeneca PLC | 4.02% | - | - |
| Abbott Laboratories | 4.44% | - | - |
| (PIPA070) PGIM Core Government Money Market Fund | 5.83% | - | - |
| Intuitive Surgical Inc | 4.16% | - | - |
| Neurocrine Biosciences Inc | 3.98% | - | - |
| PGIM Institutional Money Market Fund - D | 6.27% | - | - |
| Thermo Fisher Scientific Inc | 5.23% | - | - |
| Gilead Sciences Inc | 3.69% | - | - |
| Danaher Corp | 3.66% | - | - |